Exome-wide association study (EWAS) for central systolic blood pressure (cSBP) and eQTL plot. by Nitin Kumar (103133)

“…The eQTL violin plot demonstrated that the risk allele or alternative allele, A, for rs33975708, decreases the expression of <i>CCDC93</i>. …”

Figure 2 from PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma by Gwendolyn M. Cramer (16964052)

Clinical significance of P-class pumps in cancer (Review) by Themistocleous, Sophia C.

Get full text
Get full text
Get full text

Mutating key residues in HvHMA2 alters metal responses. by Rebecca F. Mills (121268)

Sho levels in prion-infected Tg mice expressing truncated or anchorless PrP. by Joel C. Watts (195735)

“…<p>(<b>A</b>) Western blots of brain homogenates from wt mice and Tg9949 mice (ΔN), which express MoPrP lacking residues 23–88, after infection with RML, 22L, and 301V prions. …”

The crystal structure of leptin modeled onto its receptor showing the native state dynamics in the reduced and oxidized state. by Ellinor Haglund (133097)

The main rebound results are robust to different fertility assumptions. by Dean Spears (459329)

“…In all scenarios, after 2100, TFR increases or decreases at the “medium” convergence speed of 3% per five-year period until reaching the long-run level or 2200, whichever is earlier. …”

Immunoglobulins and non-categorized immune genes exhibiting differential expression between resistant and susceptible birds. by Sarah Connell (147307)

“…Additionally the IgM (X01613.1), IgA (S40610.1) and IgY (X07174.1) heavy chain transcripts have significantly higher expression, indicating increased IgM, IgA and IgY production. …”

Effects of Lysophospholipid and Lipase Enzyme Supplementation to Low Metabolizable Energy Diets on Growth Performance, Intestinal Morphology and Microbial Population and Some Blood... by M Movagharnejad (10447205)

“…Two hundreds broiler chicks were assigned to a completely randomized design with five treatments and four replications with ten one-day old chicks. …”

Supplementary Material for: Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumo... by Knauf W. (4149052)

Treatment with activated carbon and other adsorbents as an effective method for the removal of volatile compounds in agricultural distillates by Maria Balcerek (3683623)

“…The lowest concentrations of these congeners (expressed in mg l⁻¹ alcohol 100% v/v) were measured in solutions with ethanol contents of 70–80% v/v, while solutions with an alcoholic strength by volume of 40% did not show statistically significant decreases in these compounds in relation the control sample. …”

Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an <i>in silico</i> analysis by Anchal Trivedi (9743744)

“…Towards SARS-CoV-2 main and papain-like proteases, the affinity decreased as isomeldenin > EGCG > tinosporaside and EGCG > tinosporaside > isomeldenin, respectively. …”

Representative K^trans maps for HS766t, Mia PaCa-2 and Su.86.86 tumor type from DCE-MRI (L-R). by Xiaomeng Zhang (182897)

Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection-1 by Markus Thiersch (84983)

Image_1_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

“…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”

Image_2_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

“…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”

Image_3_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

“…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”

miR-22 directly targets <i>MECOM</i> mRNA to regulate monocyte/macrophage differentiation. by Chao Shen (520343)

“…The arrows pointed differentiated monocytes/macrophages. A statistical analysis for counting differentiated monocyte/macrophages in five fields is presented in the right. …”

Image_4_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

“…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”

Image_6_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

“…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”